Dubai, UAE: Around AED 250,000 was raised by Dubai Health Authority (DHA) employees as part of Noor Dubai Foundation’s “Tolerance in Treatment Campaign”, which aims to provide treatment to people who suffer from preventable visual impartment.

As part of the annual campaign, which was launched last Ramadan, DHA staff were encouraged to donate to the foundation via text messages and the employees raised a total of AED 250,000 this year.

Their contribution will go towards providing treatment to people with limited means, who are suffering from preventable visual impartment and are living abroad, in remote areas with limited access to treatment.

The foundation made the announcement during the campaign’s award ceremony, which was held on Monday at DHA’s Innovation Centre.

The initiative was launched in line with the “Year of Tolerance”. His Highness Sheikh Khalifa bin Zayed Al Nahyan, President of the UAE, declared the year 2019 as the “Year of Tolerance” highlighting the UAE as a global capital for acceptance through its legislative and policy goals.

It is also in line with the objectives of Noor Dubai Foundation, which is a non-profit organization that has benefited more than 27 million individuals since its inception in 2008, providing treatment to preventable forms of blindness and educating the public about the causes of blindness and how to avoid them.

As part of the annual campaign, a humanitarian competition amongst the authority’s sectors and corporations was launched to encourage them to raise the highest amount of donations.

The winning sector will receive the “Tolerance Flag”. This year, the Director General’s Sector received the “Tolerance Flag” during the award ceremony after raising the highest number of donations.

During the event, His Excellency Humaid Al Qutami, Director General of the DHA and Chairman of Noor Dubai Foundation commended the innovative humanitarian initiative, launched by Noor Dubai Foundation, as it reinforced and encouraged humanitarian work amongst DHA employees.

He added that the campaign directly supports the goals of the foundation, which has successfully benefited more than 27 million individuals since its inception in 2008, providing treatment to preventable forms of blindness and educating the public about the causes of blindness and how to avoid them.

He said that the initiative is in line with the directives of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai. It is also in line with his call to all sectors, public and private, to instill the values of giving, which that have been passed on by our late founding father, His Highness Sheikh Zayed bin Sultan Al Nahyan (May his soul rest in Peace).

Dr Manal Taryam, the CEO of Noor Dubai Foundation commended the efforts exerted by all participating sectors and corporations at the DHA who made the campaign a success.

She added that the campaign will be held every year during Ramadan as a competitive humanitarian completion amongst the employees to benefit as much people as possible through the foundation’s ongoing mobile eye camps.

Al Qutami and Taryam honoured all the volunteers and sectors who contributed to the success of the campaign during the award ceremony in the presence of DHA CEOs and officials.

-Ends-

About Noor Dubai Foundation:

Noor Dubai Foundation is a UAE based charity focused on the prevention of blindness and visual impairment globally. It was launched as an initiative in 2008 by His Highness Shaikh Mohammad Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai and was later established as a Non-Governmental Organization (NGO) by Law in October 2010. Over 27 million individuals from all over Africa and Asia have benefited from the Foundation’s free treatment and preventive programs which includes provision of eye glasses and medication. As a member of the International Agency for the Prevention of Blindness (IAPB) and the Mohammed Bin Rashid Global Initiatives foundation, Noor Dubai continues to strive towards fulfilling the Vision 2020 initiative of a world free from preventable forms of blindness.

For further information, please contact:
Mahmoud Al Ali
Head of Media
Dubai Health Authority
myalali@dha.gov.ae
+9714 219 7260

Kamakshi Gupta and Noor Nazzal
Communications Analysts- Media Dept.
Dubai Health Authority
klgupta@dha.gov.ae  nnnazzal@dha.gov.ae
+9714 2197455

About the Dubai Health Authority:

The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement. 

Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.

In May 2018, H.H Sheikh Mohammed, issued Law No. (6) Of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.

According to the Law, DHA will ensure the availability of quality medical insurance programmes, improve medical services according to the highest international standards, contribute to providing attractive infrastructure for investments, boost Dubai’s position as a global hub for medical tourism and medical education, encourage innovation in the healthcare sector and improve preventive healthcare measures.

The Law specified DHA’s responsibilities to include preparing a comprehensive strategic plan for Dubai’s healthcare sector, conducting studies and surveys to define Dubai’s future needs and matching the results with future investments, licensing and monitoring medical workers and medical facilities according to DHA’s approved regulations. Its responsibilities also include regulating medical education and medical research in collaboration with competent local and international authorities and drafting and developing policies and procedures for the healthcare sector in Dubai.

The Law authorises DHA to regulate and approve the prices of medical services offered by private healthcare facilities in Dubai and ensure the quality of medical services. DHA is also responsible for regulating and facilitating the sending of patients for specialised medical treatment to healthcare facilities both within and outside the country, regulating and overseeing medical tourism in collaboration with concerned authorities, managing and developing policies that govern medical insurance and regulating medical advertising in Dubai.

H.H Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.

Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services.

In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres.

For more information, visit DHA’s website: www.dha.gov.ae 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.